Is Ecstasy the Solution for PTSD?
An international study has shown that MDMA, also known as ecstasy, may be a valuable tool for treating post-traumatic stress disorder (PTSD).
Lead author Zach Walsh said: “PTSD symptoms decreased after one session of MDMA together with psychotherapy.”
He added that 54% of participants no longer met PTSD criteria after two sessions and that there was also improvement in their symptoms of depression.
Ecstasy, also known as Molly, is the nickname for MDMA – a synthetic drug made from a combination of methylenedioxymethamphetamine.
Walsh, as well as researchers from the United States, Switzerland and Israel, examined the results from six clinical trials, involving 103 people.
Trial participants included men and women with chronic, treatment-resistant PTSD from a wide variety of causes.
Nearly 4% of all people worldwide will suffer from PTSD during their lifetime.
PTSD can be a debilitating disorder, with symptoms including intrusive thoughts and memories, negative effects on thinking and mood, depression, hyperarousal and reactivity, and avoidance.